Striatal asymmetry index and its correlation with the Hoehn & Yahr stage in Parkinson's disease

References

• Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–184.
   PubMed Web of Science ®Google Scholar
• Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33–39.
   PubMed Web of Science ®Google Scholar
• Brooks DJ, Ibanez V, Sawle GV, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol. 1990;28(4):547–555.
   PubMed Web of Science ®Google Scholar
• Song IU, Chung YA, Oh JK, et al. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease. Acta Radiol. 2014;55(3):366–371.
   PubMed Web of Science ®Google Scholar
• Kung HF, Kim HJ, Kung MP, et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med. 1996;23(11):1527–1530.
   PubMedGoogle Scholar
• Ribeiro MJ, Vidailhet M, Loc'H C, et al. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Jama Neurology. 2002;59:580–586.
   Google Scholar
• McNeill A, Wu RM, Tzen KY, et al. Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis. PLoS One. 2013;8(7):e69190
   PubMed Web of Science ®Google Scholar
• Zijlmans J, Evans A, Fontes F, et al. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease. Mov Disord. 2007;22(9):1278–1285.
   PubMed Web of Science ®Google Scholar
• Contrafatto D, Mostile G, Nicoletti A, et al. [(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism. Acta Neurol Scand. 2012;126(1):12–16.
   PubMed Web of Science ®Google Scholar
• Rinne JO, Laihinen A, Någren K, et al. PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease. Synapse. 1995;21(2):97–103.
   PubMed Web of Science ®Google Scholar
• Carpenter MB, Peter P. Nigrostriatal and nigrothalamic fibers in the rhesus monkey. J Comp Neurol. 1972;144(1):93–115.
   PubMed Web of Science ®Google Scholar
• Gerfen CR, Herkenham M, Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci. 1987;7(12):3915–3934.
   PubMed Web of Science ®Google Scholar
• Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991;114(5):2283–2301.
   PubMed Web of Science ®Google Scholar
• Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med. 1988;318(14):876–880.
   PubMed Web of Science ®Google Scholar
• Gibb WR, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1991;54(5):388–396.
   PubMed Web of Science ®Google Scholar
• Szabo J. The efferent projections of the putamen in the monkey. Exp Neurol. 1967;19(4):463–476.
   PubMed Web of Science ®Google Scholar
• Künzle H. Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis. Brain Res. 1975;88(2):195–209.
   PubMed Web of Science ®Google Scholar
• Crutcher MD, Delong MR. Single cell studies of the primate putamen. II. Relations to direction of movement and pattern of muscular activity. Exp Brain Res. 1984;53(2):244–258.
   PubMed Web of Science ®Google Scholar
• Redgrave P, Rodriguez M, Smith Y, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci. 2010;11(11):760–772.
   PubMed Web of Science ®Google Scholar
• Kempster PA, Gibb WR, Stern GM, et al. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry. 1989;52(1):72–76.
   PubMed Web of Science ®Google Scholar
• Castellano MA, Rivero FL, Rodriguez M. Spontaneous firing of nigrostriatal dopaminergic neurons in split-brain rats. Neurosci Lett. 1993;162(1-2):1–4.
   PubMed Web of Science ®Google Scholar
• Roedter A, Winkler C, Samii M, et al. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J Comp Neurol. 2001;432(2):217–229.
   PubMed Web of Science ®Google Scholar
• Boulet S, Mounayar S, Poupard A, et al. Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. J Neurosci. 2008;28(38):9575–9584.
   PubMed Web of Science ®Google Scholar
• Obeso JA, Rodriguez-Oroz MC, Lanciego JL, et al. How does Parkinson's disease begin? The role of compensatory mechanisms. Trends Neurosci. 2004;27(3):125–127.
   PubMed Web of Science ®Google Scholar
• Tang CC, Poston KL, Dhawan V, et al. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci. 2010;30(3):1049–1056.
   PubMed Web of Science ®Google Scholar
• Alvord ECJ, Forno LS, Kusske JA, et al. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem. Adv Neurol. 1974;5:175–193.
   PubMedGoogle Scholar
• Kordower JH, C Warren O, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain. 2013;136(Pt 8):2419–2431.
   PubMed Web of Science ®Google Scholar
• Greffard S, Verny M, Bonnet AM, et al. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol. 2006;63(4):584–588.
   PubMedGoogle Scholar
• Marsden CD. Parkinson's disease. Lancet. 1990;335(8695):948–952.
   PubMed Web of Science ®Google Scholar
• Damier P, Hirsch EC, Agid Y, et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain. 1999;122(8):1437–1448.
   PubMed Web of Science ®Google Scholar